RBC Cuts Price Target on Amentum Holdings to $25 From $26
RBC Capital Markets has lowered its price target for Amentum Holdings, Inc. while maintaining a 'Sector Perform' rating.
Stocks · News reference
Wall Street analysts change outlook on top names. HC Wainwright raises price target for Belite Bio, while B of A cuts Lumentum's target.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
RBC Capital Markets has lowered its price target for Amentum Holdings, Inc. while maintaining a 'Sector Perform' rating.
Amentum is supporting the development of Aiken Commons, a new nonprofit village in downtown Aiken, by providing all furnishings for the shared workspace.
Financial analysts from RBC and UBS have updated their price targets for AppLovin Corporation.
RBC Capital Markets has adjusted its price target for AppLovin Corporation from $575 to $500 while maintaining an Outperform rating.
Macquarie has revised its price target for AppLovin Corporation, lowering it from $620 to $460.
Kaplan Fox has filed a class action lawsuit against AppLovin Corporation on behalf of investors who purchased securities between February 12, 2026 and August 5, 2026. The complaint alleges that AppLovin made false statements about its generative AI video creative feature, which faced significant development delays, and overstated improvements to its AI models. The stock declined 12.65% on July 13, 2026 following analyst concerns, and another 19.66% on August 6, 2026 after the company reported below-consensus revenue and revealed its AI video tool was still a work in progress.